(Q31085628)

English

Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Christine Wurth

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Nathalie K Guimard

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Michael H Hecht

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Molecular Biology

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

319

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1279-1290

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Amyloid diseases: abnormal protein aggregation in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Solution structure of residues 1-28 of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The Alzheimer's peptide a beta adopts a collapsed coil structure in water

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Alzheimer's amyloid fibrils: structure and assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Review: model peptides and the physicochemical approach to beta-amyloids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Neuropathology of synthetic beta-amyloid peptide analogs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

In vivo aggregation of beta-amyloid peptide variants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Rapid protein-folding assay using green fluorescent protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

A simple in vivo assay for increased protein solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Computed circular dichroism spectra for the evaluation of protein conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Kinetics of aggregation of synthetic beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Amyloid fibrils from muscle myoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Quantitative analysis of protein far UV circular dichroism spectra by neural networks

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Estimation of globular protein secondary structure from circular dichroism

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

Generation of Large Libraries of Random Mutants in Bacillus subtilis by PCR-Based Plasmid Multimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900399-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-2836(02)00399-6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31085628&oldid=1771298385"